Wednesday, March 21, 2018

Merck Goes Outside -- To Covington -- For Newest General Counsel...


She is very qualified. She will be great. But I wonder whether Ms. Watson wouldn't have been at least as good an inside candidate. . . .

I also wonder whether Kenilworth will need a conflicts consent, from Gilead, in order to hire her. Or at least, whether she will be need to be "walled off" from at least some of the Hep C patent wars -- against Gilead.

Her bio at Covington indicates that she has worked extensively in helping Gilead secure its Hep C intellectual property, in challenges to the same. No dates are given, but it is probable that at least some of that work is or was adverse to Merck's claimed patent and IP positions.

Her appointment becomes effective in mid-April, as Mr. Holston heads off to GE. In any event. . . I am reasonably sure the parties will sort it all out -- and I am even more certain that she will be a stellar GC, when they do (from the presser, overnight):

. . . .“We are delighted to welcome Jennifer as our new general counsel. Her extensive experience across the biopharmaceutical industry makes her an exceptional addition to our team,” said Kenneth C. Frazier, chairman and chief executive officer, Merck.

Zachary is currently a partner at Covington & Burling in the firm’s food, drug, and device practice group where she advises a wide range of manufacturers and industry trade associations on FDA’s requirements for the development, manufacture, and distribution of prescription and over-the-counter drugs, biologics, and medical devices. Zachary began her career in FDA’s Office of Chief Counsel, where she served as an Associate Chief Counsel for Enforcement from 2005 to 2011. Zachary also served as a Special Assistant U.S. Attorney in the Civil Division of the U.S. Attorney’s Office for the District of Columbia.

"I’m honored and excited to have the opportunity to join Merck’s Executive Committee,” said Zachary. “I have long admired Merck for its steadfast commitment to its core values and I look forward to contributing to the company’s long-term success,” she said. . . .


Excellent choice -- she is a Harvard law alum, just like Mr. Frazier -- but comes with a strong chem background to boot -- and summa cum laude, at ASU! Nice -- and onward, with the domestic terrorist situation now resolved in Austin -- I will resolve. . . to smile more, today. . . . Loyola and Atlanta tomorrow. Smile.

नमस्ते

No comments: